CY1113575T1 - Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα - Google Patents

Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα

Info

Publication number
CY1113575T1
CY1113575T1 CY20131100077T CY131100077T CY1113575T1 CY 1113575 T1 CY1113575 T1 CY 1113575T1 CY 20131100077 T CY20131100077 T CY 20131100077T CY 131100077 T CY131100077 T CY 131100077T CY 1113575 T1 CY1113575 T1 CY 1113575T1
Authority
CY
Cyprus
Prior art keywords
needle
opioid
human
animal body
relates
Prior art date
Application number
CY20131100077T
Other languages
English (en)
Inventor
Jo Woodward
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1113575T1 publication Critical patent/CY1113575T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Η παρούσα εφεύρεση αφορά μία συσκευή χορήγησης δραστικής ουσίας χωρίς βελόνα, η οποία είναι κατάλληλη για την χορήγηση δραστικών ουσιών μέσω μίας επιφάνειας του δέρματος εντός ενός σώματος ανθρώπου ή ζώου, η οποία περιλαμβάνει μία φαρμακευτική σύνθεση με τουλάχιστον έναν αναλγητικό παράγοντα, ο οποίος είναι κατά προτίμηση ένα οπιοειδές. Η παρούσα εφεύρεση αφορά επίσης τη χρήση τουλάχιστον ενός αναλγητικού παράγοντα, ο οποίος είναι κατά προτίμηση τουλάχιστον ένα οπιοειδές σε μία συσκευή χορήγησης χωρίς βελόνα, η οποία είναι κατάλληλη για την έγχυση φαρμάκου μέσω μίας επιφάνειας του δέρματος εντός του σώματος ενός ανθρώπου ή ζώου. Επιπλέον, η εφεύρεση αφορά μία μέθοδο θεραπευτικής αγωγής του παροξυσμικού πόνου δια έγχυσης τουλάχιστον ενός αναλγητικού παράγοντα, ο οποίος κατά προτίμηση είναι ένα οπιοειδές, εντός του σώματος ενός ανθρώπου ή ζώου, χρησιμοποιώντας μία συσκευή χορήγησης δραστικής ουσίας χωρίς βελόνα.
CY20131100077T 2006-08-29 2013-01-28 Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα CY1113575T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119722 2006-08-29
EP07802993A EP2056825B1 (en) 2006-08-29 2007-08-29 Use of opioid formulations in needle-less drug delivery devices

Publications (1)

Publication Number Publication Date
CY1113575T1 true CY1113575T1 (el) 2016-06-22

Family

ID=38089858

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100077T CY1113575T1 (el) 2006-08-29 2013-01-28 Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα

Country Status (11)

Country Link
US (1) US8987290B2 (el)
EP (1) EP2056825B1 (el)
JP (1) JP5306207B2 (el)
CY (1) CY1113575T1 (el)
DE (1) DE202006018609U1 (el)
DK (1) DK2056825T3 (el)
ES (1) ES2398925T3 (el)
PL (1) PL2056825T3 (el)
PT (1) PT2056825E (el)
SI (1) SI2056825T1 (el)
WO (1) WO2008025790A2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
SI2266564T1 (sl) 1997-12-22 2013-07-31 Euro-Celtique S.A. Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
DE20308437U1 (de) 2002-04-05 2003-11-13 Euro Celtique Sa Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
CA2754853C (en) 2009-03-10 2015-04-28 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
CN104379112B (zh) * 2012-04-20 2018-01-30 史密斯医疗Asd公司 药物分配器
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
FR3032353B1 (fr) 2015-02-06 2017-03-10 Jacques Seguin Composition pharmaceutique et dispositif pour le traitement de la douleur
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735761A (en) * 1971-02-11 1973-05-29 Ampoules Inc Hypodermic devices
US3946732A (en) * 1973-08-08 1976-03-30 Ampoules, Inc. Two-chamber mixing syringe
SE9201246D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Injection cartridge arrangement
DE4445969C1 (de) * 1994-12-22 1996-03-14 Schott Glaswerke Spritzenzylinder für eine Zweikammer-Fertigspritze, Zweikammer-Fertigspritze und Verfahren zum Herstellen und Füllen derselben
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
SI2266564T1 (sl) 1997-12-22 2013-07-31 Euro-Celtique S.A. Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
DE10010123A1 (de) * 2000-03-03 2001-09-20 Boehringer Ingelheim Int Nadelloser Injektor in Miniaturausführung
US6689092B2 (en) * 2000-03-03 2004-02-10 Boehringer International Gmbh Needle-less injector of miniature type
KR20030071780A (ko) * 2000-11-30 2003-09-06 바이오밸브 테크놀로지스, 인코포레이티드 주입기
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
EP1379301B1 (en) * 2001-04-13 2014-06-11 Becton Dickinson and Company Intradermal needle
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
BR0211894A (pt) 2001-08-17 2005-06-28 Antares Pharma Inc Métodod de minimização e de redução dos nìveis médios de glucose, de tratamento de uma condição médica causada por nìveis elevados de glucose no sangue e de redução do valor hba1c em paciente dependente de insulina
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
GB2379390B (en) 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
US20040033253A1 (en) 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
DE20308437U1 (de) 2002-04-05 2003-11-13 Euro Celtique Sa Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
BRPI0511807C8 (pt) * 2004-06-04 2021-05-25 Camurus Ab pré-formulação, processo de formação de uma pré-formulação e uso da mesma
DE102004042581B4 (de) * 2004-09-02 2022-09-15 Ypsomed Ag Auto-Pen für Zweikammerampulle
EP1843812A4 (en) * 2005-02-01 2008-12-03 Intelliject Llc DEVICES, SYSTEMS AND METHOD FOR DISPOSING MEDICAMENTS
EP1695700A1 (en) 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
US8998881B2 (en) * 2005-08-10 2015-04-07 Alza Corporation Method for delivering drugs to tissue under microjet propulsion
US9308325B2 (en) * 2006-06-19 2016-04-12 Corium International, Inc. Methods, devices, and kits for microjet drug delivery

Also Published As

Publication number Publication date
EP2056825B1 (en) 2012-11-14
WO2008025790A3 (en) 2008-05-15
JP2010501308A (ja) 2010-01-21
DE202006018609U1 (de) 2007-05-16
US20100056554A1 (en) 2010-03-04
PT2056825E (pt) 2013-02-15
PL2056825T3 (pl) 2013-04-30
US8987290B2 (en) 2015-03-24
WO2008025790A2 (en) 2008-03-06
EP2056825A2 (en) 2009-05-13
ES2398925T3 (es) 2013-03-22
JP5306207B2 (ja) 2013-10-02
DK2056825T3 (da) 2013-02-04
SI2056825T1 (sl) 2013-06-28

Similar Documents

Publication Publication Date Title
CY1113575T1 (el) Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα
MX2009010000A (es) Dispositivo para el suministro de farmaco.
CY1120283T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης
CY1119649T1 (el) Ταχεια παγιωση και/'η περατωση της ουσιαστικης απελευθερωσης φαρμακου σταθεροποιημενης-καταστασης
CY1119582T1 (el) Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
MX2009013574A (es) Formas de dosificacion solidas o semisolidas de liberacion modificada.
CY1116727T1 (el) Θεραπεια πολλαπλης σκληρυνσης me laquinimod
BRPI0904961A2 (pt) Dispositivo médico implantável, depósito de fármaco e método de administrar um agente biologicamente ativo e clonidina ou um derivado da mesma a um tecido e de produzir um depósito de fármaco
WO2009129464A3 (en) Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
CY1121568T1 (el) Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου
EA201070757A1 (ru) Режим дозирования инъекционных препаратов эфиров палиперидона длительного действия
WO2012071559A3 (en) Therapeutic methods and compositions for solid delivery
BRPI0921845A2 (pt) formulação aquosa estéril estável, forma de dosagem unitária farmacêutica, seringa pré-carregada, e, métodos para tratar uma doença ou distúrbio, para tratar ou prevenir rejeição, para esgotar células t que expressam icos em um paciente humano, e para interromper arquitetura central germinal em um órgão linfóide secundário de um primata
BRPI0809511B8 (pt) dispositivo de distribuição transdérmica de microagulha
BR112012009376A2 (pt) composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso
AR047229A1 (es) Administracion de conjugados polimericos de peptidos y proteinas terapeuticos por medio de microproyecciones revestidas
AR063446A1 (es) Sistema de administracion para el tratamiento remoto de un animal
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
MX2009011900A (es) Curacion de herida diabetica.
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
CY1122899T1 (el) Υδατικη συσταση περιλαμβανουσα παρακεταμολη και ιβουπροφαινη
BR112012030641B8 (pt) Usos e composições para terapia farmacêutica oral
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
BRPI0921557A2 (pt) bacteriófago filamentoso, primeiro e segundo bacteriófago filamentoso para o uso no tratamento do mal de parkinson, composição farmacêutica, e , método para tratar um paciente